These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12789683)

  • 21. Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in Alzheimer brains.
    Erkinjuntti T; Skoog I; Lane R; Andrews C
    Int J Clin Pract; 2003 Nov; 57(9):756-60. PubMed ID: 14686563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rivastigmine as adjunctive therapy in the therapeutic dilemma for the treatment of hallucinations due to Parkinson disease].
    Rovers JM; Dautzenberg PL; ter Bruggen JP
    Tijdschr Gerontol Geriatr; 2006 Jul; 37(3):117-20. PubMed ID: 16886519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivastigmine in Parkinson's disease dementia.
    Chitnis S; Rao J
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rivastigmine in the treatment of Huntington's disease.
    Rot U; Kobal J; Sever A; Pirtosek Z; Mesec A
    Eur J Neurol; 2002 Nov; 9(6):689-90. PubMed ID: 12453090
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
    Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N
    Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of dementia associated with Parkinson's disease.
    Emre M
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S457-61. PubMed ID: 18267283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    van den Bliek BM; Maas HA
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2149; author reply 2149. PubMed ID: 15553363
    [No Abstract]   [Full Text] [Related]  

  • 28. Parkinson's disease in the elderly.
    Saint-Hilaire MH
    Med Health R I; 2008 May; 91(5):136-7. PubMed ID: 18549039
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neuroleptic malignant syndrome after aortic valve replacement; report of a case].
    Ichiba T; Takemoto N
    Kyobu Geka; 2003 Sep; 56(10):872-4. PubMed ID: 13677924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias.
    Ballard C; Lane R; Barone P; Ferrara R; Tekin S
    Int J Clin Pract; 2006 Jun; 60(6):639-45. PubMed ID: 16805745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.
    Chez MG; Aimonovitch M; Buchanan T; Mrazek S; Tremb RJ
    J Child Neurol; 2004 Mar; 19(3):165-9. PubMed ID: 15119476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia.
    Maidment ID; Fox C; Boustani M
    Acta Psychiatr Scand; 2005 Jun; 111(6):403-9. PubMed ID: 15877706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding rivastigmine to antipsychotics in the treatment of a chronic delirium.
    Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
    Age Ageing; 2004 Sep; 33(5):516-7. PubMed ID: 15315924
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acetylcholinesterase inhibitors].
    Rioux S
    Rev Med Suisse Romande; 2003 Jul; 123(7):471-4. PubMed ID: 15088511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can postoperative delirium be prevented pharmacologically?
    Fong JJ; Devlin JW
    Crit Care Med; 2009 May; 37(5):1825-6. PubMed ID: 19373065
    [No Abstract]   [Full Text] [Related]  

  • 39. Cholinesterase inhibitor treatment in patients with delirium.
    Berg RM; Möller K
    Lancet; 2011 Mar; 377(9769):900; author reply 901. PubMed ID: 21397758
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors.
    Bianchetti A; Rozzini R; Trabucchi M
    Curr Med Res Opin; 2003; 19(4):350-3. PubMed ID: 12841930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.